ADPT

27.9300.43%
KP

Kyle Piskel

VP, CFO & Principal Accounting Officer

Mr. Kyle Piskel serves as Principal Accounting Officer of Adaptive Biotechnologies Corporation since October 28, 2021 and serves as its Vice President. He has been Chief Financial Officer of Adaptive Biotechnologies Corporation since April 08, 2024 and also served as its Interim Chief Financial Officer since February 15, 2022 until June 2022. He has served in various roles with increasing levels of responsibility, including Corporate Controller, since joining the Adaptive Biotechnologies Corporation in September 2015. Prior to joining Adaptive Biotechnologies Corporation, he was an Accounting Manager at Expedia Group from October 2014 to August 2015. Prior to joining Expedia Group, he was in the Assurance services practice at Ernst and Young, LLP from August 2007 to October 2014. He is a certified public accountant and holds a BA in Business Administration from Eastern Washington University and a Master of Accountancy from Gonzaga University.

Positions